Used as a sympathomimetic agent and appetite suppressant in the management of obesity. It acts as a central nervous system stimulant by promoting the release of norepinephrine and dopamine, leading to reduced appetite and increased energy expenditure. Employed as part of a short-term weight loss regimen, typically in conjunction with diet, exercise, and behavioral modification. Its (R)-enantiomer exhibits greater pharmacological activity compared to the (S)-form, contributing to enhanced efficacy in appetite suppression. Due to its amphetamine-like structure, it is regulated as a controlled substance and used under medical supervision to minimize risk of dependence or misuse.